Nautilus Biotechnology, a Seattle-based biotech startup led by Isilon co-founder Sujal Patel, is the latest company to go public using a special purpose...
23andMe is a leading consumer genetics and research company that offers a personalized health and wellness experience, and has built a premier genetic...
Sana Biotechnology raised $587.5 million in an initial public offering, a significant cash haul that the 3-year-old Seattle company will use to continue...
Editor’s note: Sana Biotechnology priced shares on Wednesday evening, raising $587.5 million. See full story here.
Sana Biotechnology — the Seattle upstart that’s looking...
HONG KONG, Feb 3, 2021 - (ACN Newswire) - The American Dream is why the United States is considered the "land of opportunity," and why for centuries...
Consumer DNA-testing company 23andMe Inc. is in talks to go public through a roughly $4 billion deal with VG Acquisition Corp., a special purpose acquisition company...
